Main Session
Sep
28
PQA 04 - PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology
2791 - Immune Checkpoint Inhibitor Combined with Radiotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma: A Transplant-Free Retrospective Study
Presenter(s)
Yue Liu, - Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC, Beijing,